Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 18,269 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Primary Total Hip Arthroplasty, Primary Total Knee Arthroplasty
Interventions: Diphenhydramine (Benadryl), Melatonin, Sleep Hygiene Education; Drug · Dietary Supplement · Behavioral
Lead sponsor: James A. Keeney; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Epilepsy
Interventions: Photobiomodulation; Other
Lead sponsor: Cynthia Kerson; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: North Miami, Florida • Cincinnati, Ohio • Warren, Ohio + 1 more

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Home-based MT through Supervised, Supported Singing (H3S), Individualized Music Therapy (IMT), Attention Control (AtCon); Behavioral · Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 55 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: New York, New York

Conditions: Duchenne Muscular Dystrophy
Interventions: VECTTOR; Device
Lead sponsor: Alan Neuromedical Technologies, LLC; Industry
Eligibility: 8 Years to 20 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Periodontitis, Diabetes Mellitus Type 2
Interventions: local antibiotic application of topical minocycline, Scaling and Root Planing; Drug · Procedure
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Peanut Allergy
Interventions: Peanut flour OIT; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 7 Years to 21 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Food Allergies
Interventions: Food Drops: Food Allergens (peptides); Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 4 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Major Depression, Post-Traumatic Stress Disorder
Interventions: Depression Care Quality Improvement Implementation; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 6
States / cities: Long Beach, California • Shreveport, Louisiana • Minneapolis, Minnesota + 3 more

Conditions: Venous Thromboembolism, Pulmonary Embolism
Interventions: VTE prophylaxis with Enoxaparin 30mg BID, VTE prophylaxis with Aspirin 81mg BID; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Peripheral Neuropathy, Neuropathic Pain
Interventions: ADL5859, Duloxetine, Placebo; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years to 75 Years
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 27
States / cities: Riverside, California • Torrance, California • Kissimmee, Florida + 21 more

Conditions: Alcohol Dependency
Interventions: SBIRT; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 791 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Diego, California

Conditions: Diabetes, Cardiovascular Disease
Interventions: Twitter Diabetes Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years and older
Enrollment: 628 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obese, Obesity
Interventions: HM15275, Placebo of HM15275; Drug
Lead sponsor: Hanmi Pharmaceutical Company Limited; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 14
States / cities: Chula Vista, California • Oak Lawn, Illinois • Ames, Iowa + 10 more

Conditions: Chronic Stable Plaque Psoriasis
Interventions: DFD06-Cream, Vehicle Cream; Drug
Lead sponsor: Promius Pharma, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 30
States / cities: Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 27 more

Conditions: Hereditary Angioedema, HAE
Interventions: BCX7353 capsules, Placebo oral capsule; Drug
Lead sponsor: BioCryst Pharmaceuticals; Industry
Eligibility: 12 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 27
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 24 more

Conditions: Opioid Sensitivity, Individual Difference, Abuse Opioids
Interventions: Within-subject test of blinded study medication; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Type 1 Diabetes
Interventions: Family-based cognitive-behavioral treatment; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Asthma
Interventions: GW642444M, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years and older
Enrollment: 614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 30
States / cities: Phoenix, Arizona • Fresno, California • Huntington Beach, California + 25 more

Conditions: Prostate Cancer
Interventions: Randomized Exercise Intervention; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: BPSD, Caregiver Distress, Well-being, Mood
Interventions: Personalized Music Listening (PML), Binaural Beat Music (BBM), Spatialized Music (SM); Other
Lead sponsor: Maharishi International University; Other
Eligibility: 55 Years to 95 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Denver, Colorado • Lakewood, Colorado

Conditions: Knee Osteoarthritis
Interventions: Percutaneous Pulsed Radiofrequency, Physical Therapy; Device · Procedure
Lead sponsor: VA Long Beach Healthcare System; Federal
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH)
Interventions: Standard of care acceptance-based behavioral weight loss program, Occupational therapy dietary and lifestyle modifications; Behavioral
Lead sponsor: Grand Valley State University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Wyoming, Michigan

Conditions: Type 2 Diabetes Mellitus
Interventions: Effect of Physical Activity on Type II Diabetes Mellitus; Behavioral
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: 19 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 2
States / cities: Pittsfield, Massachusetts • Springfield, Massachusetts

Conditions: Rheumatoid Arthritis
Interventions: Fostamatinib and placebo injections, Adalimumab and placebo of fostamatinib, Placebo of fostamatinib, fostamatinib, and placebo injections; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 644 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 40
States / cities: Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 37 more

Search by objective public record fields.

Total Joint Arthroplasty and Sleep

An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Duchenne Muscular Dystrophy Clinical Trial

Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics

Oral Peanut Immunotherapy

Sublingual Immunotherapy for Food Allergy

Expanding and Testing VA Collaborative Care Models for Depression

A Different Approach to Preventing Thrombosis

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Alcohol Screening, Brief Intervention, and Referral to Treatment in a Military Treatment Facility

Twitter and Diabetes

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans

Supporting Treatment Adherence Needs in Diabetes

Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.

Exercising Together: An Intervention for Prostate Cancer Survivors and Spouses

Effects of Binaural Beats and Spatialized Music on Behavioural and Psychological Symptoms of Dementia in Assisted Living Facility Residents

A Controlled Comparison of Pulsed Radiofrequency Vs Physical Therapy on Treating Chronic Knee Osteoarthritis

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring

Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)